<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005465</url>
  </required_header>
  <id_info>
    <org_study_id>4909</org_study_id>
    <secondary_id>R01HL046880</secondary_id>
    <nct_id>NCT00005465</nct_id>
  </id_info>
  <brief_title>Genetic Mapping of Atherogenic Lipoprotein Phenotypes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <brief_summary>
    <textblock>
      To map the major gene influencing low-density lipoprotein subclass phenotypes, denoted&#xD;
      atherogenic lipoprotein (ALP) phenotypes, with a long term goal of cloning the ALP gene and&#xD;
      understanding its role in genetic susceptibility to atherosclerosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      ALP phenotype B (ALP-B), characterized by a predominance of small, dense LDL particles as&#xD;
      determined by gradient gel electrophoresis, has been associated with increased risk of&#xD;
      myocardial infarction and a constellation of atherogenic lipid and apolipoprotein (apo)&#xD;
      changes. Based on complex segregation analysis, ALP-B appeared to be influenced by a single&#xD;
      major genetic locus with a dominant mode of inheritance and a common allele frequency. This&#xD;
      project was designed to identify a new gene involved in susceptibility to coronary heart&#xD;
      disease.&#xD;
&#xD;
      DESIGN NARRATIVE:&#xD;
&#xD;
      The investigators identified, collected and constructed a repository of immortalized cell&#xD;
      lines and lipid and apo measurements from members of families informative for ALP. They&#xD;
      tested genes implicated in lipoprotein metabolism as possible candidate ALP genes and used&#xD;
      highly informative DNA probes to search the genome for linkage to the ALP gene. They also&#xD;
      refined the model for the inheritance of ALP phenotypes and tested for genetic-environmental&#xD;
      interactions. Forty informative families were recruited for the repository. The families were&#xD;
      identified through two sources of probands: former participants in a cholesterol-lowering&#xD;
      diet study and patients seen at the lipid clinics at the University of Washington. Each&#xD;
      participating family member completed a medical history questionnaire and provided a blood&#xD;
      sample for ALP phenotype determination, for DNA studies, and for lipid and apo measurements.&#xD;
      Linkage studies and LOD score analyses began with a candidate gene approach, and continued by&#xD;
      using DNA probes that revealed restriction fragment length polymorphisms (RFLPs) to search&#xD;
      the genome for linkage to the ALP gene. When a linkage was found, ALP genotype information&#xD;
      was used to refine the statistical model describing the inheritance of ALP phenotypes, and to&#xD;
      evaluate genetic-environmental interactions involving lipid and apo levels and environmental&#xD;
      and behavioral factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 1991</start_date>
  <completion_date>July 1996</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Atherosclerosis</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Austin MA, Talmud PJ, Luong LA, Haddad L, Day IN, Newman B, Edwards KL, Krauss RM, Humphries SE. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet. 1998 Feb;62(2):406-19. doi: 10.1086/301712.</citation>
    <PMID>9463319</PMID>
  </reference>
  <reference>
    <citation>Austin MA. Genetic epidemiology of dyslipidaemia and atherosclerosis. Ann Med. 1996 Oct;28(5):459-63. doi: 10.3109/07853899608999108.</citation>
    <PMID>8949979</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Edwards KL. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol. 1996 Jun;7(3):167-71. doi: 10.1097/00041433-199606000-00010.</citation>
    <PMID>8818515</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Selby JV. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S22-6.</citation>
    <PMID>7550534</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol. 1994 Dec;5(6):395-403. doi: 10.1097/00041433-199412000-00002.</citation>
    <PMID>7712044</PMID>
  </reference>
  <reference>
    <citation>Austin MA. Small, dense low-density lipoprotein as a risk factor for coronary heart disease. Int J Clin Lab Res. 1994;24(4):187-92. doi: 10.1007/BF02592460.</citation>
    <PMID>7894041</PMID>
  </reference>
  <reference>
    <citation>Austin MA. Genetic and environmental influences on LDL subclass phenotypes. Clin Genet. 1994 Jul;46(1 Spec No):64-70. doi: 10.1111/j.1399-0004.1994.tb04204.x.</citation>
    <PMID>7988081</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Hokanson JE. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am. 1994 Jan;78(1):99-115. doi: 10.1016/s0025-7125(16)30178-x.</citation>
    <PMID>8283937</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Jarvik GP, Hokanson JE, Edwards K. Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol. 1993;10(6):599-604. doi: 10.1002/gepi.1370100645.</citation>
    <PMID>8314067</PMID>
  </reference>
  <verification_date>May 2001</verification_date>
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

